To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
Already a subscriber? Enter your email address below and click "Find" to look up and manage your current contact details and subscription preferences.
FDA approves Adlyxin to treat type 2 diabetes
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2…